About Echo Therapeutics
Echo Therapeutics is a Healthcare company based in Franklin (United States) founded in 1989. Non-invasive glucose monitoring is enabled by wearables and mobile apps. It operates in the Healthcare and Technology sectors. Echo Therapeutics has raised $15.04 million across 12 funding rounds. Its focus areas include High Tech, Wearable Technology, Health and Wellness Devices and Diabetes Monitoring. Its competitors include Dexcom, Livongo and Senseonics; 3 of its 3 listed competitors have raised funding.
Company details
Echo Therapeutics provides a glucose sensor for continuous and non-invasive glucose monitoring, which is paired with a mobile application and a wearable for data display. Their technology is backed by a skin preparation device, which exfoliates dead skin, that is further used in glucose sensing. Patients get real-time feedback for behavior modifications, specifically food intake, in order to improve their disease condition. Also developing an API for developers to build their own apps for Echos glucose monitoring system. Partnered with MTIA and Handok. Went public in 2011.
- Headquarters Franklin, United States
- SectorsHealthcareTechnology
- Website echotx.com
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$15.04M (USD)
in 12 rounds
- Latest Funding Round$5.1M (USD), Post-IPO
May 2016
Apps and channels of Echo Therapeutics
its YouTube channel Lazada Indonesia has 13.5K subscribers and 30 videos.
Videos from Echo Therapeutics
The most watched videos on Echo Therapeutics's YouTube channel, Lazada Indonesia (13.5K subscribers). Click a video to play it here.
More on Lazada Indonesia.
Funding Insights of Echo Therapeutics
Echo Therapeutics has successfully raised a total of $15.04M across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5.1 million completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15.04M
- Total Rounds 12
- Last Round Post-IPO — $5.1M
- First Round $2.01M
(Jul 2009)
Latest 10 of 12 funding rounds of Echo Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2016 | $5.1M | Post-IPO | – | – | – |
| Feb 2016 | $1.79M | Post-IPO | – | – | – |
| Dec 2014 | $4M | Post-IPO | – | – | – |
| Dec 2013 | $10M | Post-IPO | – | – | – |
| Jun 2013 | $12.5M | Post-IPO | – | – | – |
| Aug 2012 | $20M | Post-IPO | – | – | – |
| Feb 2011 | $3.51M | Series B | – | – | – |
| Jan 2011 | $5.5M | Series B | – | – | – |
| Oct 2010 | $2.46M | Series A | – | – | – |
| Dec 2009 | $562,500 | Series A | – | – | – |
Timeline of Echo Therapeutics
3 dated milestones of Echo Therapeutics across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Echo Therapeutics is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Post-IPO, of $5.1M.
Competitors of Echo Therapeutics
Echo Therapeutics has 3 listed competitors in our database, 3 of them funded. They include Dexcom, Livongo and Senseonics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dexcom.com | 1999 | San Diego, United States | $52.5M | 9,600 | Wearable glucose monitoring patches are provided for real-time data tracking. | |
| livongo.com | 2014 | San Francisco, United States | $237M | 3,263 | Provider of smart devices for diabetes management for patients and doctors | |
| senseonics.com | 1996 | Germantown, United States | $175.46M | 132 | Implantable continuous glucose monitoring systems are provided for diabetes management. |
Detailed competitors of Echo Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Echo Therapeutics
Websites that share an audience with Echo Therapeutics (echotx.com).
Websites whose visitors overlap most with Echo Therapeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pfenex.com | 100% | View details | |||
cdn.jdrf.org | cdn.jdrf.org | 66% | – | ||
diabeteshealth.com | diabeteshealth.com | 64% | #5,132,848 | – | |
topics.nytimes.com | topics.nytimes.com | 39% | – | ||
finance.yahoo.com | finance.yahoo.com | 37% | #205 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Echo Therapeutics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diabetes
3 companies that operate in the same segment as Echo Therapeutics (Diabetes) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Echo Therapeutics
Echo Therapeutics was founded in 1989 and raised its 1st funding round 20 years after it was founded.
Echo Therapeutics is headquartered in Franklin, United States.
Echo Therapeutics is a funded company, having raised a total of $15.04M across 12 funding rounds to date. The company's 1st funding round was a Series A of $562.5K, raised on Jul 2009.
Echo Therapeutics provides a glucose sensor for continuous and non-invasive glucose monitoring, which is paired with a mobile application and a wearable for data display. Their technology is backed by a skin preparation device, which exfoliates dead skin, that is further used in glucose sensing. Patients get real-time feedback for behavior modifications, specifically food intake, in order to improve their disease condition. Also developing an API for developers to build their own apps for Echos glucose monitoring system. Partnered with MTIA and Handok. Went public in 2011.
Echo Therapeutics's top competitors include Dexcom, Senseonics and Livongo.